摘要
目的比较口服和静脉应用消炎痛治疗新生儿动脉导管未闭的疗效。方法将我院58例新生儿动脉导管未闭随机分为口服组和静脉组,应用的消炎痛的剂量和用法一样,治疗后复查心脏彩超。结果口服应用消炎痛动脉导管未闭治愈率为81.3%,静脉应用消炎痛动脉导管未闭治愈率为84.6%,两组无显著性差异(P>0.05)。结论两种用药方式的治愈率无差异,但静脉给药剂量易准确把握,相对副作用小,值得推荐。
Objective : To compare oral and intravenous indomethacin for closure of patent ductus axteriosus . Methods : 58 newborns with patent ductus axteriosus were random divided into two groups, oral group and intravenous group were administered the same dose and usage indomethacin . Two groups were checked again by echocardiography after treatment. Results: The difference rate of cure between oral group (81.3%) and intravenous group (84. 6% ) was no significantly ( P 〉0. 05). Conclusion: There were no difference in two groups, we recommended intravenous indomethacin because less side effect and accurate dose.
出处
《中国优生与遗传杂志》
2007年第5期86-86,106,共2页
Chinese Journal of Birth Health & Heredity
关键词
动脉导管未闭
消炎痛
Patent ductus axteriosus
Indomethacin